Inhibition of Proteolytic and Hemorrhagic Activities by Ethyl Acetate Extract of Eclipta prostrata. Against Malayan Pit Viper Venom

References

• Bhargava KK, Krishnaswamy NR, Seshadri TR (1972): Demethylwedelolactone glucoside from Eclipta alba. leaves. Indian J Chem 10: 810–811.
   Google Scholar
• Bjarnason JB, Fox JW (1989): Hemorrhagic toxins from snake venoms. J Toxicol Toxin Rev 7: 121–209.
   Web of Science ®Google Scholar
• Bjarnason JB, Fox JW (1994): Hemorrhagic metalloproteinase from snake venoms. Pharmacol Ther 62: 325–372.
   PubMed Web of Science ®Google Scholar
• Bjarnason JB, Tu AT (1978): Hemorrhagic toxins from Western diamondback rattlesnake (Crotalus atrox.) venom: Isolation and characterization of five toxins and the role of zinc in hemorrhagic toxin. Biochemistry 17: 3395–3404.
   PubMed Web of Science ®Google Scholar
• Bode W, Huber R (2000): Structural basis of the endoproteinase-protein inhibitor interaction. Biochim Biophys Acta 1477: 241–252.
   PubMed Web of Science ®Google Scholar
• Castro O, Gutierrez JM, Barrios M, Castro I, Romero M, Umana E (1999): Neutralization of the hemorrhagic effect induced by Bothrops asper. (Serpentes: Viperidae) venom with tropical plant extracts. Rev Biol Trop 47: 605–616.
   PubMed Web of Science ®Google Scholar
• Chanhome L, Cox MJ, Wilde H, Jintakoon P, Chaiyabutr N, Sitprija V (1998): Venomous snakebite in Thailand I: Medically important snakes. Mili Med 163: 310–317.
   PubMed Web of Science ®Google Scholar
• Dambisya YM, Lee TL, Gopalakrishnakone P (1994): Action of Calloselasma rhodostoma. (Malayan pit viper) venom on human blood coagulation and fibrinolysis using computerized thromboelastography (CTEG). Toxicon 32: 1619–1626.
   PubMed Web of Science ®Google Scholar
• Devaraj T (1979): Bleeding manifestations in snakebite. Southeast Asian J Trop Med Public Health 10: 255–257.
   PubMedGoogle Scholar
• Gondachari TR, Nagarajan K, Pai BR (1956): Wedelolactone from Eclipta alba.. Tetrahedron Lett 15: 664–665.
   Google Scholar
• Gutierrez JM, Gene JA, Rojas G, Cerdas L (1985): Neutralization of proteolytic and hemorrhagic activities of Costa Rica snake venoms by a polyvalent antivenom. Toxicon 23: 887–893.
   PubMed Web of Science ®Google Scholar
• Gutierrez JM, Avila C, Rojas E (1988): An alternative in vitro. method for testing the potency of the polyvalent antivenom produced in Costa Rica. Toxicon 26: 411–413.
   PubMed Web of Science ®Google Scholar
• Khin MM, Nyunt N, Khin MT (1978): The protective effect of Eclipta alba. on carbon tetrachloride-induced acute liver damage. Toxicol Appl Pharmacol 45: 723–728.
   PubMed Web of Science ®Google Scholar
• Kini RM, Evans HJ (1992): Structural domains in venom proteins: Evidence that metalloproteinases and nonenzymatic platelet aggregation inhibitors (disintegrins) from snake venoms are derived by proteolysis from a common precursor. Toxicon 30: 265–293.
   PubMed Web of Science ®Google Scholar
• Kondo H, Kondo S, Ikezawa H (1960): Studies on the quantitative method for determination of haemorrhagic activity of Habu snake venom. Jpn J Med Sci Biol 13: 43–51.
   PubMedGoogle Scholar
• Krishnaswamy NR, Seshadri TR, Sharma BR (1966): The structure of polythienyl from Eclipta alba.. Tetrahedron Lett 35: 4227–4230.
   Google Scholar
• Kunitz M (1947): Crystalline soybean trypsin inhibitor II: General properties. J Gen Physiol 30: 291–310.
   PubMed Web of Science ®Google Scholar
• Laemmli UK (1970): Cleavage of structure protein during the assembly of the head of bacteriophage T4. Nature 227: 680–685.
   PubMed Web of Science ®Google Scholar
• Leal LKAM, Ferreira AAG, Bezerra GA, Matos FJA, Vina GSB (2000): Antinociceptive, anti-inflammatory and bronchodilator activities of Brazilian medicinal plants containing coumarin: A comparative study. J Ethnopharmacol 70: 151–159.
   PubMed Web of Science ®Google Scholar
• Looareesuwan S, Viravan C, Warrell DA (1988): Factors contributing to fatal snake bite in the rural tropics: Analysis of 46 cases in Thailand. Trans R Soc Trop Med Hyg 82: 930–934.
   PubMed Web of Science ®Google Scholar
• Markland FS (1998): Snake venoms and the hemostatic system. Toxicon 36: 1780–1800.
   Web of Science ®Google Scholar
• Melo PA, Ownby CL (1999): Ability of wedelolactone, heparin, and para.-bromophenacyl bromide to antagonize the myotoxic effects of two crotaline venoms and their PLA2 myotoxins. Toxicon 37: 199–215.
   PubMed Web of Science ®Google Scholar
• Melo PA, do Nascimento MC, Mors WB, Suarez-Kurtz G (1994): Inhibition of the myotoxic and haemorrhagic activities of crotalid venoms by Eclipta prostrata. (Asteraceae) extracts and constituents. Toxicon 32: 595–603.
   PubMed Web of Science ®Google Scholar
• Melo PA, Almeida MAL, do Nascimento MC, Mors WB (1997): Ability of wedelolactone and its analogs to antagonize Bothrops venom activity. J Venom Anim Toxins 3: 184.
   Google Scholar
• Mors WB (1991): Plants active against snake bite. In: Wagner H, Farnsworth NR, eds., Economic and Medicinal Plant Research, Vol 5. London, Academic Press, pp. 353–373.
   Google Scholar
• Mors WB, do Nascimento MC, Parente JP, da Silva MH, Melo PA, Suarez-Kurtz G (1989): Neutralization of lethal and myotoxic activities of South American rattle snake venom by extracts and constituents of the plant Eclipta prostrata. (Asteraceae). Toxicon 27: 1003–1009.
   PubMed Web of Science ®Google Scholar
• Ohsaka A (1979): Hemorrhagic, necrotizing and edema-forming effects of snake venoms. In: Lee CY, ed., Snake Venoms: Handbook of Experimental Pharmacology, Vol 5. Berlin, Springer-Verlag, pp. 480–546.
   Google Scholar
• Otero R, Nunez V, Jimenez SL, Fonnergra R, Osorio RG (2000): Snakebites and ethnobotany in the northwest region of Colombia Part II: Neutralization of lethal and enzymatic effects of Bothrops atrox. venom. J Ethnopharmacol 71: 505–511.
   PubMed Web of Science ®Google Scholar
• Ouyang C, Hwang LJ, Huang TF (1983): α-Fibrinogenase from Agkistrodon rhodostoma. (Malayan pit viper) venom. Toxicon 21: 25–33.
   PubMed Web of Science ®Google Scholar
• Pithayanukul P, Laovachirasuwan S, Bavovada R, Pakmanee N, Suttisri R (2004): Anti-venom potential of butanolic extract of Eclipta prostrata. against Malayan pit viper venom. J Ethnopharmacol 90: 347–352.
   PubMed Web of Science ®Google Scholar
• Pithayanukul P, Ruenraroengsak P, Bavovada R, Pakmanee N, Suttisri R, Saen-oon S (2005): Inhibition of Naja kaouthia. venom activities by plant polyphenols. J Ethnopharmacol 97: 527–533.
   PubMed Web of Science ®Google Scholar
• Ponnudurai G, Chung MCM, Tan NH (1993): Isolation and characterization of a hemorrhagin from the venom of Calloselasma rhodostoma. (Malayan pit viper). Toxicon 31: 997–1005.
   PubMed Web of Science ®Google Scholar
• Reed L, Muench H (1938): A simple method of estimating 50 percent end point. Am J Hyg 27: 493–497.
   Google Scholar
• Reid HA, Chan KE (1968): The paradox in therapeutic defibrination. Lancet 9: 485–486.
   Google Scholar
• Tan NH, Kanthimathi MS, Tan CS (1986): Enzymatic activities of Calloselasma rhodostoma. (Malayan pit viper) venom. Toxicon 24: 626–630.
   PubMed Web of Science ®Google Scholar
• Tan NH, Ponnudurai G, Chung MCM (1997): Proteolytic specificity of rhodostoxin, the major hemorrhagin of Calloselasma rhodostoma. (Malayan pit viper) venom. Toxicon 35: 979–984.
   PubMed Web of Science ®Google Scholar
• Theakston RDG, Reid HA (1983): Development of simple standard assay procedures for the characterization of snake venom. Bull WHO 61: 949–956.
   PubMed Web of Science ®Google Scholar
• Valente RH, Dragulev B, Perales J, Fox JW, Domont GB (2001): BJ45a, a snake venom metalloproteinase inhibitor. Eur J Biochem 268: 3042–3052.
   PubMedGoogle Scholar
• Viravan C, Looareesuwan S, Kosakarn W, Wuthiekanun V, McCarthy CJ, Stimson AF, Bunnag D, Harinasuta T, Warrell DA (1992): A national hospital-based survey of snakes responsible for bites in Thailand. Trans R Soc Trop Med Hyg 86: 100–106.
   PubMed Web of Science ®Google Scholar
• Wagner H, Fessler B (1986): In vitro. 5-lipoxygenase hemmung durch Eclipta alba. extrakte und das coumestan derivat wedelolactone. Planta Med 52: 374–377.
   Google Scholar
• Wagner H, Geyer B, Kiso Y, Hikino H, Rao GS (1986): Coumestans as the main active principles of the liver drugs Eclipta alba. and Wedelia calendulacea.. Planta Med 52: 370–374.
   Google Scholar